Insulet Corporation

NasdaqGS:PODD Stock Report

Market Cap: US$17.1b

Insulet Future Growth

Future criteria checks 5/6

Insulet is forecast to grow earnings and revenue by 23.1% and 15% per annum respectively. EPS is expected to grow by 22.8% per annum. Return on equity is forecast to be 21% in 3 years.

Key information

23.1%

Earnings growth rate

22.78%

EPS growth rate

Medical Equipment earnings growth16.2%
Revenue growth rate15.0%
Future return on equity20.99%
Analyst coverage

Good

Last updated27 Feb 2026

Recent future growth updates

Insulet Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nov 09
Insulet Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Recent updates

Insulet: The Growth Doesn't Stop Here

Feb 27

Insulet Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nov 09
Insulet Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues Pushing Shares 26% Higher

Sep 06
Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues Pushing Shares 26% Higher

There May Be Reason For Hope In Insulet's (NASDAQ:PODD) Disappointing Earnings

Aug 14
There May Be Reason For Hope In Insulet's (NASDAQ:PODD) Disappointing Earnings

Insulet (NASDAQ:PODD) Has A Rock Solid Balance Sheet

Aug 04
Insulet (NASDAQ:PODD) Has A Rock Solid Balance Sheet

Does Insulet (NASDAQ:PODD) Deserve A Spot On Your Watchlist?

Jul 22
Does Insulet (NASDAQ:PODD) Deserve A Spot On Your Watchlist?

Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

Jun 25
Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue

What Is Insulet Corporation's (NASDAQ:PODD) Share Price Doing?

May 28
What Is Insulet Corporation's (NASDAQ:PODD) Share Price Doing?

Subdued Growth No Barrier To Insulet Corporation (NASDAQ:PODD) With Shares Advancing 26%

May 15
Subdued Growth No Barrier To Insulet Corporation (NASDAQ:PODD) With Shares Advancing 26%

We Ran A Stock Scan For Earnings Growth And Insulet (NASDAQ:PODD) Passed With Ease

Apr 21
We Ran A Stock Scan For Earnings Growth And Insulet (NASDAQ:PODD) Passed With Ease

Does Insulet (NASDAQ:PODD) Have A Healthy Balance Sheet?

Apr 07
Does Insulet (NASDAQ:PODD) Have A Healthy Balance Sheet?

Insulet Leans Bullish (Technical Analysis)

Mar 18

Calculating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Mar 05
Calculating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines

Nov 20

Insulet: Turning More Constructive, Valuations Still Stretched

Sep 05
User avatar

Omnipod 5'S Global Expansion And New Integrations Promise Growth Amid Market And Manufacturing Risks

Expansion into new international markets and integration with leading diabetes sensors position Insulet for increased global penetration and competitive advantage.

Earnings and Revenue Growth Forecasts

NasdaqGS:PODD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20284,63971766882317
12/31/20273,93656756463625
12/31/20263,30444145956125
12/31/20252,708247350569N/A
9/30/20252,522246408534N/A
6/30/20252,360236392516N/A
3/31/20252,199402281407N/A
12/31/20242,072418296430N/A
9/30/20241,984421218328N/A
6/30/20241,873395173276N/A
3/31/20241,781234137233N/A
12/31/20231,69720637146N/A
9/30/20231,557120-15151N/A
6/30/20231,46563-26152N/A
3/31/20231,3681-45133N/A
12/31/20221,3055-38119N/A
9/30/20221,24317-6343N/A
6/30/20221,17835-141-40N/A
3/31/20221,14245-152-47N/A
12/31/20211,09917-191-68N/A
9/30/20211,037-29-199-26N/A
6/30/2021996-30-12644N/A
3/31/20219599-12053N/A
12/31/20209047-8284N/A
9/30/202086829-15114N/A
6/30/202082618-25101N/A
3/31/20207775-6588N/A
12/31/201973812-7298N/A
9/30/201969417N/A82N/A
6/30/201965317N/A67N/A
3/31/201960014N/A47N/A
12/31/20185643N/A36N/A
9/30/2018529-13N/A27N/A
6/30/2018500-17N/A35N/A
3/31/2018486-23N/A59N/A
12/31/2017464-27N/A41N/A
9/30/2017437-29N/A39N/A
6/30/2017410-30N/A19N/A
3/31/2017387-26N/A5N/A
12/31/2016367-27N/A16N/A
9/30/2016347-34N/A-23N/A
6/30/2016324-49N/A-17N/A
3/31/2016297-62N/A-20N/A
12/31/2015264-62N/A-13N/A
9/30/2015253-51N/A11N/A
6/30/2015256-44N/A7N/A
3/31/2015268-56N/A6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PODD's forecast earnings growth (23.1% per year) is above the savings rate (3.4%).

Earnings vs Market: PODD's earnings (23.1% per year) are forecast to grow faster than the US market (15.5% per year).

High Growth Earnings: PODD's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PODD's revenue (15% per year) is forecast to grow faster than the US market (10.2% per year).

High Growth Revenue: PODD's revenue (15% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PODD's Return on Equity is forecast to be high in 3 years time (21%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/05 02:46
End of Day Share Price 2026/03/04 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Insulet Corporation is covered by 46 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Travis SteedBarclays
Matthew MiksicBarclays